I am an adult who took escitalopram (Lexapro) 5 mg daily for 7 weeks, tapered to 2.5 mg, and now have persistent anxiety, flu‑like symptoms, gastrointestinal upset, insomnia, significant weight loss, and loss of sexual interest. What is the likely cause and how should I manage it?

SSRI Discontinuation Syndrome with Severe Withdrawal After Rapid Escitalopram Taper

You are experiencing classic SSRI discontinuation syndrome compounded by reinstatement instability; the severe anxiety, cognitive symptoms, and physical manifestations you describe are directly attributable to the abrupt 50% dose reduction of escitalopram followed by rapid reinstatement, and your symptoms should gradually resolve over the next 4–8 weeks as your brain re-adapts to the reinstated 5 mg dose. 1, 2

Understanding What Happened

Your symptom timeline fits the established pattern of escitalopram discontinuation syndrome:

• The panic attack and "brain chaos" on the second day of your taper represent acute withdrawal from dropping escitalopram from 5 mg to 2.5 mg—a 50% reduction that was far too rapid. 1, 2

• Discontinuation syndrome typically manifests within 24–48 hours of dose reduction and includes exactly what you experienced: dizziness, anxiety, irritability, sensory disturbances (your "buzzy and warm" arms), confusion, and the terrifying "something is wrong" feeling. 1, 2

• The flu-like symptoms, nausea, sweating, hot flashes, and gastrointestinal upset that emerged after reinstating 5 mg represent your nervous system's acute response to the medication change—essentially a collision between withdrawal and re-exposure. 1

• Higher escitalopram doses and plasma concentrations significantly increase discontinuation syndrome risk; even at your relatively low 5 mg dose, the 50% reduction was pharmacologically destabilizing. 2

Why Your Anxiety Changed and Worsened

The new, constant baseline anxiety with mental loops, hyperawareness, and existential questioning differs fundamentally from your original situational anxiety:

• This represents treatment-emergent anxiety from medication destabilization, not a return of your original condition. 1

• Your brain's serotonin system was disrupted by the rapid taper and reinstatement, creating a state of heightened arousal and cognitive hypervigilance that manifests as the relentless mental loops and derealization symptoms you describe. 1, 2

• The anxiety about your relative and the inability to engage in previously comfortable activities (sex, showering, self-care) reflect the severity of this withdrawal-induced anxiety state. 1

Expected Recovery Timeline

• Most discontinuation symptoms resolve within 2–4 weeks after stabilizing on a consistent dose, though some patients experience protracted symptoms lasting 6–8 weeks or longer. 1, 2

• You are currently at week 7–8 post-reinstatement (based on your timeline), which means you are approaching the outer edge of the typical recovery window but may need additional time. 2

• The fact that your sleep has stabilized since week 6 is an encouraging sign that your nervous system is beginning to re-equilibrate. 1

• Approximately 50% of patients who ultimately achieve remission with escitalopram do so between weeks 6 and 14 of stable dosing, suggesting you may need another 4–6 weeks at 5 mg before declaring treatment failure. 3

Immediate Management Strategy

Do not make any medication changes for at least 4 more weeks (until you reach 12 weeks post-reinstatement):

• Maintain escitalopram 5 mg daily without alteration; any dose change now will restart the destabilization cycle. 3, 1

• Your nervous system requires uninterrupted time at a stable dose to recover from the taper-reinstatement trauma. 1, 2

• Monitor weekly for gradual improvement in the constant baseline anxiety, mental loops, and hyperawareness—recovery is typically gradual rather than sudden. 3

Addressing the Weight Loss and Functional Impairment

Your 10–18 pound weight loss and inability to maintain self-care routines are concerning:

• Nausea and decreased appetite are common escitalopram side effects that typically emerge within the first few weeks and often resolve with continued treatment. 1

• However, your weight loss is severe enough to warrant medical evaluation—ensure you are not developing a comorbid eating disorder or medical condition. 1

• The morning dread and inability to shower suggest significant functional impairment that may require additional intervention beyond waiting for medication stabilization. 1

When to Consider Next Steps (After 12 Weeks Total)

If your severe anxiety, mental loops, and functional impairment persist after 12 weeks at 5 mg escitalopram:

• Add cognitive-behavioral therapy (CBT) immediately—combination therapy demonstrates superior efficacy compared to medication alone for anxiety disorders, and CBT can be initiated without waiting for medication optimization. 3

• Consider increasing escitalopram to 10 mg daily after the full 12-week stabilization period; the therapeutic dose range for anxiety disorders is 10–20 mg daily, and your current 5 mg dose may be subtherapeutic. 3, 4

• Allow 4 weeks at 10 mg before further dose escalation; if partial response occurs, maintain that dose for an additional 4 weeks before increasing to 20 mg. 3

• Do not exceed 20 mg daily without cardiac monitoring, as higher doses increase QT-interval prolongation risk. 3

Alternative Medication Strategy (If Escitalopram Fails)

If you complete an adequate trial (12 weeks at 10–20 mg) without improvement:

• Switch to sertraline 50–200 mg daily using a gradual cross-taper over 3–4 weeks to minimize withdrawal symptoms. 3, 5

• Sertraline has comparable efficacy to escitalopram for anxiety and depression but may be better tolerated in some patients. 3, 5

• The cross-taper protocol: Reduce escitalopram by 25–50% weekly while simultaneously starting sertraline at 25 mg and increasing by 25 mg weekly until reaching 50–100 mg. 3, 6

Critical Safety Monitoring

• Assess for suicidal ideation at every contact during the next 8 weeks; suicide risk peaks during the first 1–2 months after medication changes, and you are in a high-risk window. 3, 1

• Monitor for serotonin syndrome if any new medications are added: confusion, agitation, tremor, hyperreflexia, tachycardia, diaphoresis. 1

• Do not combine escitalopram with other serotonergic agents (triptans, tramadol, St. John's Wort, other antidepressants) without close monitoring. 1

• Do not abruptly discontinue escitalopram again—any future taper must be extremely gradual (10% dose reductions every 2–4 weeks minimum). 2

What NOT to Do

• Do not increase escitalopram dose now—your nervous system needs stability, not another change. 3, 1

• Do not switch to a different SSRI before completing 12 weeks at therapeutic escitalopram dose (10–20 mg)—premature switching delays recovery. 3

• Do not add benzodiazepines for longer than 2–4 weeks—they carry abuse potential, dependence risk, and cognitive impairment. 7

• Do not attempt another taper until you have been stable and symptom-free for at least 6–12 months. 2

Addressing Your Specific Concerns

The derealization symptoms ("is life even real," "am I even real") are recognized manifestations of severe anxiety and discontinuation syndrome, not psychosis or permanent brain damage. 1

The anxiety about your relative likely represents generalized hypervigilance that has attached to a previously safe relationship; this should resolve as your nervous system stabilizes. 1

The inability to have sex reflects both the direct sexual side effects of escitalopram (present in 9% of patients) and the severity of your anxiety state. 1

Your symptoms will improve—discontinuation syndrome is self-limiting, and the vast majority of patients recover fully with time and medication stability. 1, 2